Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
45 Cards in this Set
- Front
- Back
intracellular signaling reactions
|
ion transport, metabolism, gene expression, cell movement
|
|
cytokines
|
polypeptides as autocrine or paracrine regulators
|
|
hormones
|
secreted by endocrine glands as polypeptides or steroids as autocrine or paracrine regulators
|
|
used by intracellular receptors
|
steroid hormones, derivatives of vitamin D3, retinoic acid and thyroid hormone
|
|
effects of binding of a molecule to a receptor
|
second messenger cascade, change in membrane potential, enzyme cascade
|
|
Four major classes of cell surface receptors
|
ligand-gated ion channel, enzyme-linked, cytokine, G-protein coupled
|
|
example of a ligand that evokes multiple responses
|
acetylcholine- relaxation in cardiac muscle by G-protein or contraction in skeletal muscle by ion channel
|
|
effectors
|
signaling proteins( enzymes or ion channels) that react with a receptor
|
|
G-proteins
|
coupling proteins between receptors and effectors
|
|
second messengers
|
Ca, AMP, GMP, DAG, IP3
|
|
most pathways of intracellular transduction use this to alter protein function
|
phosphorylation
|
|
most protein kinases phosphorylate these
|
serine, threonine or tyrosine residues
|
|
phosphatases
|
remove phosphate and inactivate proteins
|
|
ways cells terminate signal transduction
|
reducing ligand availability, degradation of receptor complex, receptor inactivation
|
|
Function of N and C terminals in enzyme-linked receptors
|
N- extracellular and contain binding domain;C- intracellular and contain domain for catalytic activity
|
|
receptor tyrosine kinases
|
enzyme-linked receptor, component of receptor protein
|
|
dimerization of receptor tyrosine kinases have these effects
|
activates the kinase domain, triggers endocytic internalization of the growth factor/receptor tyrosine kinase complex resulting in degradation
|
|
Ras
|
GTPase critical in cell proliferation; present in 30% of human tumors; bind to and stim. serine/threonine kinases and trigger MAP cascade
|
|
MAP
|
mitogen activating proteins; stimulate mitotic activity
|
|
transforming growth factor B and bone morphogenic proteins
|
families of growth regulatory factors required for fetal and neonatal dev. and maintenance of differentiated phenotype in adults
|
|
mutations in these receptors cause progression of cancer
|
transforming growth factor B and bone morphogenic proteins
|
|
these growth factors cause dimerization and activation of serine-threonine kinases
|
transforming growth factor B and bone morphogenic proteins
|
|
SMAD's
|
part of serine-threonine kinase cascade; translocate to nucleus and bind to DNA regulatory seq.
|
|
interleukins and interferons
|
cytokines
|
|
plasma receptors for cytokines lack these
|
tyrosine or serine/threonine kinase activity- bind nonreceptor tyrosine kinases which are soluble proteins
|
|
STAT's
|
signal transducers and activators of transcription- gene reg. protein binding to phos. cytokine receptor- translocate to nucleus, bind to DNA and activate genes
|
|
NFkB
|
activated by cytokine receptors- can regulate any gene
|
|
alpha subunits of G proteins
|
guanine nucleotide binding site, GTPase activity and effector domains
|
|
G-protein subunits
|
alpha, beta and gamma- 20 types of alpha-specifies G-protein
|
|
G-protein stimulation
|
GDP occupies nucleotide binding site at rest-GPCR binds ligand-GDP released, GTP binds and alpha subunit leaves
|
|
termination of GPCR pathway
|
phosphorylation of receptor by kinases like PKA
|
|
breakdown of cAMP
|
catalyzed by cyclic nucleotide phosphodiesterases (PDE's) that hydrolyze cyclic diester bond to make AMP
|
|
stim of adenylyl cyclase
|
alpha s subunit of G-protein-inc. in cAMP
|
|
cAMP pathway
|
bind to PKA and break tetramer-kinase sites activated-moves to nucleus-phosphorylates cAMP-regulated gene regulatory proteins(CREB)
|
|
these facilitate PKA translocation to the nucleus
|
nuclear localization sequences
|
|
what does cGMP regulate
|
cellular contractility and blood volume homeostasis
|
|
regulation of cGMP levels
|
guanylate cyclase-synthesis
cGMP phosphodiesterases-degredation |
|
are guanylate cyclases membrane bound or free
|
either
|
|
where to find membrane bound guanylate cyclases
|
cells which express receptors for ANF-vascular smooth muscle and renal
|
|
what happens when the NO in guanylate cyclase binds heme
|
catalytic activity is increased leading to cGMP formation
|
|
phospholipase C
|
an enzyme that generates IP3 by hydrolyzing inositol phospholipids-stim. by hormones or neurotransmitters
|
|
phospholipase D
|
enzymes that hydrolyze choline or ethanolamine phospholipids-phosphatidic acid-diacylglycerol
|
|
phospholipase A2
|
enzymes that catalyze phospholipids producing free fatty acids-arachidonic acid
|
|
DAG
|
second messenger that binds and activates protein kinase C
|
|
crosstalk
|
integration of signals between cells from extracellular stimuli-causes variation in pathway response due to other pathways
|